Medical Network Spółka z o.o. Trials

Medical Network Spółka z o.o.	Welcome, Profile Billing Logout

Medical Network Spółka z o.o.

Welcome, Profile Billing Logout

0 Trials

1 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tabaza, Alaa

NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Recruiting

618

Europe, US, RoW

Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo

Cristcot LLC, Cristcot HCA LLC

Ulcerative Proctitis

06/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites